GALT Galectin Therapeutics Inc.
$3.63▼ -5.39%
Healthcare
Other
Volume 127.9K
Avg Volume (10D) 363.0K
Key Metrics & Fundamentals
Market Cap
$366.40M
P/E Ratio
–
Div Yield
–%
52W Range
2.03 - 7.13
% vs 50 MA
0.16%
% vs 200 MA
12.90%
RSI-14
48.5
MACD Histogram
-0.0400
Beta (1Y vs SPY)
0.74
Free Cash Flow
-$2.44M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.95M
COGS
–
Operating Exp
$3.98M
Operating Income
-$3.98M
EBIT
-$3.98M
Pretax Income
-$9.11M
Net Income
-$9.11M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 12:00 PM
Liver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight
PR Newswire · Aug 24, 2026 2:31 PM
Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 14, 2026 12:00 PM
Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
GlobeNewswire · Aug 4, 2026 12:00 PM
GALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASH
Zacks · Jun 24, 2026 2:05 PM
GALT Stock Surges 22% — On Track For Best Day In Over A Year After FDA Clears Path For Late-Stage Belapectin Trial
Stocktwits · Jun 23, 2026 5:47 PM
Galectin Therapeutics Says FDA Alignment Reached on Phase 3 Belapectin Trial
MT Newswires · Jun 23, 2026 12:44 PM
Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
GlobeNewswire · Jun 23, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See GALT's money flow as a full page
Social Sentiment
Avg -0.80 · 3 posts
TradeDiscussionDiversified biotech short portfolio - completely tweaked on naked short calls (-20 500$)
r/wallstreetbets · Apr 30, 2025
The author views GALT as a 'con-artist' with no profitable product pipeline and expresses concern.
very_negative
-0.80
Can someone help explain this, new to option trading, transaction with $GALT
r/stocks · Dec 21, 2024
The comments about a 'chance of going to 0.50$' and IV drops indicate a pessimistic outlook on GALT's future prospects.
negative
-0.80
DDPriceTargetNewsShkrelli found a new short: $GALT predicted to go down 99%
r/options · Dec 19, 2024
The post centers on a negative price prediction for GALT, driven by a short thesis.
very_negative
-0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.